91 related articles for article (PubMed ID: 18645736)
21. Efficacy of nicergoline treatment in Parkinson's disease associated with dementia.
Lee S; Na SH; Chung YA; Jeong H; Song IU
J Clin Neurosci; 2019 Dec; 70():136-139. PubMed ID: 31431403
[TBL] [Abstract][Full Text] [Related]
22. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
[TBL] [Abstract][Full Text] [Related]
23. Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer's disease.
Hanyu H; Shimizu T; Tanaka Y; Takasaki M; Koizumi K; Abe K
Dement Geriatr Cogn Disord; 2003; 15(4):177-82. PubMed ID: 12626849
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
[TBL] [Abstract][Full Text] [Related]
25. The DONPAD-study--treatment of dementia in patients with Parkinson's disease with donepezil.
Müller T; Welnic J; Fuchs G; Baas H; Ebersbach G; Reichmann H
J Neural Transm Suppl; 2006; (71):27-30. PubMed ID: 17447412
[TBL] [Abstract][Full Text] [Related]
26. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
27. A pilot study for the effects of donepezil therapy on cerebral and optic nerve head blood flow, visual field defect in normal-tension glaucoma.
Yoshida Y; Sugiyama T; Utsunomiya K; Ogura Y; Ikeda T
J Ocul Pharmacol Ther; 2010 Apr; 26(2):187-92. PubMed ID: 20415624
[TBL] [Abstract][Full Text] [Related]
28. Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
Montastruc JL; Celsis P; Agniel A; Demonet JF; Doyon B; Puel M; Marc-Vergnes JP; Rascol A
Mov Disord; 1987; 2(4):279-89. PubMed ID: 3509776
[TBL] [Abstract][Full Text] [Related]
29. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
30. Dopa-induced blood flow responses in nonhuman primates.
Hershey T; Black KJ; Carl JL; Perlmutter JS
Exp Neurol; 2000 Dec; 166(2):342-9. PubMed ID: 11085899
[TBL] [Abstract][Full Text] [Related]
31. Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.
Tei E; Yamamoto H; Watanabe T; Miyazaki A; Nakadate T; Kato N; Mimura M
Growth Horm IGF Res; 2008 Feb; 18(1):47-54. PubMed ID: 17714966
[TBL] [Abstract][Full Text] [Related]
32. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease.
Ceravolo R; Volterrani D; Tognoni G; Dell'Agnello G; Manca G; Kiferle L; Rossi C; Logi C; Strauss HW; Mariani G; Murri L
Clin Neuropharmacol; 2004; 27(4):166-70. PubMed ID: 15319702
[TBL] [Abstract][Full Text] [Related]
33. Cerebral blood flow in patients with peritoneal dialysis by an easy Z-score imaging system for brain perfusion single-photon emission tomography.
Isshiki R; Kobayashi S; Iwagami M; Tsutumi D; Mochida Y; Ishioka K; Oka M; Maesato K; Moriya H; Ohtake T; Hidaka S
Ther Apher Dial; 2014 Jun; 18(3):291-6. PubMed ID: 24965295
[TBL] [Abstract][Full Text] [Related]
34. Increased plasma donepezil concentration improves cognitive function in patients with dementia with Lewy bodies: An exploratory pharmacokinetic/pharmacodynamic analysis in a phase 3 randomized controlled trial.
Mori E; Ikeda M; Nakai K; Miyagishi H; Nakagawa M; Kosaka K
J Neurol Sci; 2016 Jul; 366():184-190. PubMed ID: 27288803
[TBL] [Abstract][Full Text] [Related]
35. Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
Gu C; Shen T; An H; Yuan C; Zhou J; Ye Q; Liu T; Wang X; Zhang T
Neurosci Lett; 2015 Oct; 606():13-7. PubMed ID: 26297124
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Hanaoka T; Okazaki T; Arakawa R
J Neuroimaging; 2012 Jul; 22(3):299-304. PubMed ID: 21699607
[TBL] [Abstract][Full Text] [Related]
37. Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.
Ceravolo R; Volterrani D; Frosini D; Bernardini S; Rossi C; Logi C; Manca G; Kiferle L; Mariani G; Murri L; Bonuccelli U
J Neural Transm (Vienna); 2006 Nov; 113(11):1787-90. PubMed ID: 16758132
[TBL] [Abstract][Full Text] [Related]
38. Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy.
Staff RT; Gemmell HG; Shanks MF; Murray AD; Venneri A
Nucl Med Commun; 2000 Jan; 21(1):37-41. PubMed ID: 10717900
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneous factors in dementia with Parkinson's disease: IMP-SPECT study.
Matsui H; Nishinaka K; Oda M; Hara N; Komatsu K; Kubori T; Udaka F
Parkinsonism Relat Disord; 2007 Apr; 13(3):174-81. PubMed ID: 17145197
[TBL] [Abstract][Full Text] [Related]
40. Effects of donepezil on central processing speed and attentional measures in Parkinson's disease with dementia and dementia with Lewy bodies.
Rowan E; McKeith IG; Saxby BK; O'Brien JT; Burn D; Mosimann U; Newby J; Daniel S; Sanders J; Wesnes K
Dement Geriatr Cogn Disord; 2007; 23(3):161-7. PubMed ID: 17192712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
